Widnell KL - Search Results

1

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group. Olanow CW, et al. Among authors: widnell kl. Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Epub 2013 Dec 20. Lancet Neurol. 2014. PMID: 24361112 Free PMC article. Clinical Trial.

2

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.

Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Shaw LM, Trojanowski JQ, Singleton A, Frasier M, Marek K, Galasko D; Parkinson's Progression Marker Initiative. Mollenhauer B, et al. Neurology. 2017 Nov 7;89(19):1959-1969. doi: 10.1212/WNL.0000000000004609. Epub 2017 Oct 13. Neurology. 2017. PMID: 29030452 Free PMC article.

3

Pathophysiology of motor fluctuations in Parkinson's disease.

Widnell K. Widnell K. Mov Disord. 2005;20 Suppl 11:S17-22. doi: 10.1002/mds.20459. Mov Disord. 2005. PMID: 15822108 Review.

4

The Parkinson Progression Marker Initiative (PPMI).

Parkinson Progression Marker Initiative. Parkinson Progression Marker Initiative. Prog Neurobiol. 2011 Dec;95(4):629-35. doi: 10.1016/j.pneurobio.2011.09.005. Epub 2011 Sep 14. Prog Neurobiol. 2011. PMID: 21930184 Free PMC article. Review.

5

Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro.

Widnell KL, Russell DS, Nestler EJ. Widnell KL, et al. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10947-51. doi: 10.1073/pnas.91.23.10947. Proc Natl Acad Sci U S A. 1994. PMID: 7971989 Free PMC article.

6

Role of COMT inhibitors and dopamine agonists in the treatment of motor fluctuations.

Widnell KL, Comella C. Widnell KL, et al. Mov Disord. 2005;20 Suppl 11:S30-7. doi: 10.1002/mds.20461. Mov Disord. 2005. PMID: 15822107 Review.

7

Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens.

Widnell KL, Self DW, Lane SB, Russell DS, Vaidya VA, Miserendino MJ, Rubin CS, Duman RS, Nestler EJ. Widnell KL, et al. J Pharmacol Exp Ther. 1996 Jan;276(1):306-15. J Pharmacol Exp Ther. 1996. PMID: 8558448

8

Transcriptional regulation of CREB (cyclic AMP response element-binding protein) expression in CATH.a cells.

Widnell KL, Chen JS, Iredale PA, Walker WH, Duman RS, Habener JF, Nestler EJ. Widnell KL, et al. J Neurochem. 1996 Apr;66(4):1770-3. doi: 10.1046/j.1471-4159.1996.66041770.x. J Neurochem. 1996. PMID: 8627337

9

Differential regulation of corticotropin-releasing factor1 receptor expression by stress and agonist treatments in brain and cultured cells.

Iredale PA, Terwilliger R, Widnell KL, Nestler EJ, Duman RS. Iredale PA, et al. Among authors: widnell kl. Mol Pharmacol. 1996 Nov;50(5):1103-10. Mol Pharmacol. 1996. PMID: 8913341

10

Cell type-specific regulation of CREB gene expression: mutational analysis of CREB promoter activity.

Coven E, Ni Y, Widnell KL, Chen J, Walker WH, Habener JF, Nestler EJ. Coven E, et al. Among authors: widnell kl. J Neurochem. 1998 Nov;71(5):1865-74. doi: 10.1046/j.1471-4159.1998.71051865.x. J Neurochem. 1998. PMID: 9798910 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters